tiprankstipranks
Trending News
More News >

IDEAYA Biosciences Appoints New Chief Financial Officer

Story Highlights
IDEAYA Biosciences Appoints New Chief Financial Officer

Don’t Miss TipRanks’ Half-Year Sale

An announcement from IDEAYA Biosciences ( (IDYA) ) is now available.

On June 26, 2025, IDEAYA Biosciences appointed Joshua Bleharski, Ph.D. as Chief Financial Officer and Principal Financial Officer. This strategic appointment may influence the company’s financial management and operational strategies.

The most recent analyst rating on (IDYA) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on IDEAYA Biosciences stock, see the IDYA Stock Forecast page.

Spark’s Take on IDYA Stock

According to Spark, TipRanks’ AI Analyst, IDYA is a Neutral.

IDEAYA Biosciences’ stock score is primarily impacted by its financial performance challenges, including declining revenues and net losses. Positive technical indicators provide some support, indicating potential short-term momentum. However, the lack of profitability and valuation concerns weigh heavily on the overall score.

To see Spark’s full report on IDYA stock, click here.

More about IDEAYA Biosciences

Average Trading Volume: 1,439,189

Technical Sentiment Signal: Sell

Current Market Cap: $1.93B

For a thorough assessment of IDYA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1